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Background: Zinc influx transporters (ZIPs) 
together with zinc efflux transporters (ZnTs) 
regulate cellular zinc homeostasis. 
Results: Down-regulation of ZIP6 and ZIP7 
expression impairs glucose-stimulated insulin 
secretion via reduced 1st phase insulin exocytosis. 
Conclusion: ZIP6 and ZIP7 are functionally 
important for maintaining proper insulin secretion 
in pancreatic beta cells.  
Significance: ZIP6 and ZIP7 represent novel 
proteins that contribute to the insulin secretory 
pathway. 
ABSTRACT 
 Zinc plays an essential role in the 
regulation of pancreatic beta cell function, 
affecting important processes including 
proinsulin biosynthesis, glucose-stimulated 
insulin secretion, and cell viability. Mutations 
in zinc efflux transport protein ZnT8 have been 
linked with both type 1 and type 2 diabetes, 
further supporting an important role for zinc in 
glucose homeostasis. However, very little is 
known about how cytosolic zinc is controlled by 
zinc influx transporters, ZIPs. In the current 
study, we have examined the beta cell and islet 
ZIP transcriptome and show consistent high 
expression of ZIP6 (Slc39a6) and ZIP7 (Slc39a7) 
genes across human and mouse islets, and 
MIN6 beta cells. Modulation of ZIP6 and ZIP7 
expression significantly altered cytosolic zinc 
influx in pancreatic beta cells, indicating an 
important role for ZIP6 and ZIP7 in regulating 
cellular zinc homeostasis. Functionally, this 
dysregulated cytosolic zinc homeostasis led to 
impaired insulin secretion. In parallel studies, 
we identified both ZIP6 and ZIP7 as potential 
interacting proteins with GLP-1R by a 
membrane yeast-two-hybrid (MYTH) assay. 
Knock-down of ZIP6 but not ZIP7 in MIN6 
beta cells impaired the protective effects of 
GLP-1 on fatty acid-induced cell apoptosis, 
possibly via reduced activation of the p-ERK 
pathway. Thus, our data suggest that ZIP6 and 
ZIP7 function as two important zinc influx 
transporters to regulate cytosolic zinc 
concentrations and insulin secretion in beta 
cells. In particular, ZIP6 is also capable of 
directly interacting with GLP-1R to facilitate 
the protective effect of GLP-1 on beta cell 
survival. 
INTRODUCTION 
 Zinc is a critical micronutrient required for 
numerous cellular processes including DNA and 
protein synthesis, enzyme activity, and 
intracellular signalling [1,2]. Importantly, zinc 
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plays an essential role in insulin-producing 
pancreatic islet beta cells, in which zinc content is 
among the highest in the body [3]. Intracellular 
zinc homeostasis is tightly regulated by two major 
families of zinc transport proteins, the Zrt- and Irt-
like proteins (ZIPs) and zinc efflux (ZnTs) 
transporters. In general, the ZIP family is 
responsible for zinc influx into cytosol from 
extracellular sources and intracellular organelles, 
and conversely, the ZnT family is responsible for 
efflux. The fine balance between specific ZIPs and 
ZnTs regulate both cytosolic and intra-organelle 
zinc concentrations. 
 At present 10 members of the ZnT family 
(ZnT1-10; encoded by Slc30a1-10) and 14 
members of the ZIP family (ZIP1-14; encoded by 
Slc39a1-14) have been identified in humans. The 
expression of specific ZIPs and ZnTs in cells is 
tissue-dependent, and closely tied to cellular 
function [4,5]. Previous work by our group and 
others using whole body and pancreatic beta cell-
specific ZnT8 knockout mouse models have 
highlighted the importance of zinc and zinc 
transporters in beta cell function and glucose 
homeostasis [6,7,8,9]. These studies showed, 
among other things, that ZnT8 is required for 
proper insulin biosynthesis and crystallization, 
presumably by regulating zinc entry into insulin 
secretory vesicles [10,11]. Based on these findings, 
it is not surprising that studies in humans point to a 
role for ZnT8 in the pathophysiology of type 2 
diabetes [7,12,13], further exemplifying the 
importance of zinc transporters in beta cells. 
 Beyond Znt8, however, little is known 
about how zinc levels are regulated in beta cells. 
Most importantly, it is not well understood how 
zinc enters beta cells and how this entrance is 
regulated to thereby affect cytosolic zinc 
concentrations. We have previously shown that 
voltage-gated calcium channels (VGCC) can act as 
zinc influx transporters [14] during cellular 
membrane depolarization associated with high 
glucose concentrations. However, zinc also enters 
the beta cell under resting/low glucose conditions, 
indicating there is another mechanism of influx 
which is likely independent of VGCCs. Our 
previous work has identified several ZIPs in beta 
cells that may contribute to zinc homeostasis. 
Currently, limited information is available 
regarding the function of these ZIPs in pancreatic 
beta cells. Although, a few studies have suggested 
that ZIPs, specifically ZIP4 [15], may play some 
role in the regulation of pancreatic beta cell zinc 
homeostasis [16,17].  
 In the present study, we show consistent 
expression of ZIP6 and ZIP7 across islets and beta 
cell lines, suggesting they are prominent zinc 
influx transporters in pancreatic beta cells. Our 
data suggests that ZIP6 and ZIP7 work together 
with the ZnT family to regulate cytosolic zinc 
homeostasis in this cell type. Functionally, down-
regulation of ZIP6 and ZIP7 in pancreatic beta 
cells reduces cytosolic zinc content, which causes 
impaired insulin exocytosis and thus reduced 
glucose-stimulated insulin secretion (GSIS). 
Interestingly, we also show that ZIP6 interacts 
physically with the glucagon-like peptide 1 
receptor (GLP-1R). This interaction mediates the 
protective effects of GLP-1 on beta cells apoptosis.  
MATERIALS AND METHODS 
Cell Culture and Transfection 
MIN6 beta cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM; 
4500 mg/L glucose, L-glutamine; Sigma, Oakville, 
Canada) supplemented with 10% fetal bovine 
serum, 1% penicillin/streptomycin and 50uM beta-
mercaptoethanol. INS-1 832/3 cells (from Dr. 
Chris Newgard at Duke University, Durham, USA) 
were maintained in RPMI-1640 (11.1mM D-
glucose) supplemented with 10% FBS, 100 U/mL 
penicillin, 100 μg/mL streptomycin, 10mM 
HEPES, 2mM L-glutamine, 1mM sodium 
pyruvate, and 50 μM beta-mercaptoethanol. Cells 
were incubated at 37°C in a 5% CO2 humidified 
incubator. The culture medium was changed every 
48-72 h until the optimal confluence for treatment. 
MIN6 beta cells were cultured in 96-well plates 
until ~80% confluent. Cells were transfected with 
30 pmol/well of targeted siRNA specific to ZIP6 
and ZIP7 or a non-silencing control siRNA 
(scramble) mixed with Lipofectamine RNAiMAX 
(Life Technologies, Burlington, Canada) 
transfection reagent according to the 
manufacturer’s instructions. Alternatively, cells 
were transfected with 0.25μg/well of plasmid 
cDNA targeted specifically to over-express ZIP6 
(pcDNA3.1-ZIP6-HA, a gift from Kyle W. Sloop, 
Lilly Research Laboratories) and ZIP7 
(pcDNA3.1-ZIP7-FLAG, OriGene, Rockville, 
USA) or empty vector (pcDNA3.1) as control 
mixed with Lipofectamine 2000 (Life 
Technologies, Burlington, Canada) transfection 
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reagent according to the manufacturer’s 
instructions. Cells were recovered overnight 
before any functional studies performed.
Gene Expression and Western Blotting 
 Total RNA was isolated from transfected 
cells using the RNeasy mini kit (Qiagen, Toronto, 
Canada) in accordance with the manufacturer’s 
instructions. Quality and quantity of RNA was 
determined by spectrophotometric measurement. 
Reverse transcription from total RNA and 
quantitative real time PCR (qPCR) analysis was 
performed as previously described [6]. Primers 
were adopted from previous publications [6,18] or 
designed using Primer3 software (NCBI) (primer 
sequences are available upon request). Data was 
normalized to beta actin mRNA. ZIP6 and ZIP7 
targeted cDNA plasmid and empty vector 
(pcDNA3.1) treated MIN6 beta cells were lysed in 
RIPA buffer (Cell Signaling, Danvers, USA) 
containing protease and phosphatase inhibitor 
cocktail (Cell Signaling, Danvers, USA). Lysates 
were loaded onto a 10% SDS-PAGE gradient gel 
(BioRad, Mississauga, Canada) and transferred 
onto PVDF membrane using a Trans Blot Turbo 
(BioRad, Mississauga, Canada). The membrane 
was probed with anti-HA (1:1,000, Covance Inc, 
Montreal, Canada), anti-FLAG (1:1,000, Sigma, 
Oakville, Canada), anti-phospho-ERK (1:1,000, 
Cell Signaling, Danvers, MA, USA), and anti-α 
actinin antibodies (1:1,000, Cell Signaling, 
Danvers, MA, USA) followed by anti-mouse 
(1:5,000) or anti-rabbit (1:5,000) secondary 
antibody (Cell Signaling, Danvers, MA, USA), 
and imaged using Kodak Imager 4000pro 
(Molecular Imaging Systems, Carestream Health 
Inc, Rochester, NY, USA) within the linear range 
of intensity. Co-immunoprecipitation (co-IP) 
experiments were performed to examine the 
interaction between proteins. HA-tagged ZIP7 and 
Flag-tagged GLP-1R plasmids, or Flag-tagged 
ZIP6 and His-V5-tagged GLP-1R were co-
transfected into MIN6 cells using Lipofectamine 
2000 (Life Technologies, Burlington, Canada). 
Anti-Flag co-IP was conducted to pull down both 
bait protein and its interacting partners. 2.5% input 
and 50% co-IP eluents were loaded for gel 
electrophoresis and immunoblotting by anti-HA 
(1:5000, Covance Inc, Montreal, Canada) or anti-
V5 (1:5000, Life Technologies, Burlington, 
Canada) primary antibody. 
Confocal Microscopy Imaging
 The cellular localization of ZIP6 and ZIP7 
was determined in primary dispersed mouse islet 
cells and MIN6 beta cells using confocal 
microscopy. Staining was performed as previously 
described [6] with primary anti-HA (1:1,000, 
Covance Inc, Montreal, Canada), anti-FLAG 
(1:500, Sigma, Oakville, Canada), anti-KDEL 
(1:200, Pierce, ThermoFisher, Rockford, USA), 
anti-Syntaxin-1a (1:200, Sigma, Oakville, 
Canada), anti-ZIP7 (1:200, Proteintech, Chicago, 
USA), anti-ZIP6-Y3 (1:20, in house generated 
antibody from Kathryn M Taylor from Cardiff 
University, UK [19]), or anti-insulin, (1:100, Dako, 
Burlington, Canada) primary, followed by Alexa 
Fluor® 488 Goat Anti-Mouse (1:500, Molecular 
Probe, Life Technologies, Burlington, Canada), 
Alexa Fluor® 555 Donkey Anti-Rabbit (1:500, 
Molecular Probe, Life Technologies, Burlington, 
Canada), or Donkey Anti-Guinea pig (1:500, 
Jackson ImmunoResearch, West Grove, USA) 
secondary antibody. Images were acquired on 
Zeiss confocal microscope at 40x magnification 
with an oil lens and analysed by LSM510 (Zeiss, 
NY, USA). Co-localization of ZIP6 and ZIP7 with 
membrane and ER staining was analyzed and 
determined with Volocity software. 
Mouse, Human Islet Isolation and Dispersion 
and Glucose-Stimulated Insulin Secretion 
(GSIS) 
 Mouse islets were isolated by collagenase 
type V (Sigma, Oakville, Canada) digestion and 
dispersed by AccutaseTM (Millipore, Etobicoke, 
Canada) as described previously [20,21]. Human 
islets from review board-approved healthy donors 
were provided by the Islet Core and Clinical Islet 
Laboratory (University of Alberta, Alberta, 
Canada). GSIS was assessed as previously 
described [6,22] using 0mM, 2mM and 20mM 
glucose. 48 h after transfection, growth medium 
was removed, and cells were pre-incubated with 
KRB (Krebs-Ringer Bicarbonate) buffer 
(128.8mM NaCl, 4.8mM KCl, 1.2mM KH2PO4, 
1.2mM MgSO4, 2.5mM CaCl2, 5mM NaHCO3, 
10mM HEPES, and 0.1% BSA (bovine serum 
albumin) (pH 7.4)) for 60 min at 37°C. Pre-
incubation medium was removed, and cells were 
incubated under no glucose (0mM glucose), low 
glucose (2mM glucose), high glucose (11mM or 
20mM glucose), then KCl (20mM glucose + 
30mM KCl), or GLP-1 (11mM glucose + 100mM 
GLP-1) conditions respectively for 20 min each at 
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37°C. Incubation medium was collected after each 
condition and stored at -20°C. Ultrapure water was 
added to each well and then frozen and thawed to 
lyse cells. DNA content was determined by 
spectrophotometric measurement. Insulin 
concentration in collected media fractions and cell 
lysate were determined using a homogenous time 
resolved fluorescence (HTRF) insulin assay 
(Cisbio, Bedford, USA) in accordance with the 
manufacturer’s instructions on the PHERAstar 
plate reader (BMG Labtech, Ortenberg, Germany). 
Insulin levels were then normalized to DNA 
content for each treatment. 
High Content Imaging and Microscopy 
 Images were acquired and analyzed on a 
Thermo Fisher Cellomics ArrayScan® VTI HCS 
Reader using iDEVTM software. The filter settings 
for each dye were Ex/Em:494/516nm for 
FluoZinTM3AM and Fluo4AM (Molecular Probe, 
Life Technologies, Burlington, Canada), 
Ex/Em:644/655nm for CellROX (Molecular Probe, 
Life Technologies, Burlington, Canada) and 
Ex/Em:350/461nm for Hoechst 33342 (Molecular 
Probe, Life Technologies, Burlington, Canada).  
Each dye was loaded into live MIN6 beta cells or 
dispersed mouse islet cells according to 
manufacturer’s recommendation. For transmission 
electron microscopy (TEM) images, MIN6 cells 
were transfected with either scramble siRNA or 
targeted siRNA for ZIP6 and ZIP7 knock-down, 
fixed, and images acquired as previously described 
[23]. Granule number was manually quantified 
using ImageJ software [24]. TIRFM images were 
acquired by a Nikon TE2000U TIRF microscope 
at 5 Hz with a 100 ms exposure time. Insulin 
granule mobilization and exocytosis were 
analyzed by Matlab (Math Works), ImageJ (NIH), 
and Igor Pro software. For detailed analysis please 
refer to previous publication [25]. 
Mitochondrial Membrane Potential (MMP) 
 Primary dispersed mouse islets were 
transfected with either scramble siRNA or targeted 
siRNA for knocking down ZIP6 and ZIP7 
expression 48 hrs prior to loading with rhodamine 
123 (25ug/ml, 10mins) in 2.8mM glucose imaging 
buffer. Cells were treated with extra glucose (final 
concentration 20mM) to observe the 
correspondent change of mitochondrial membrane 
potential. Images were taken at 10s intervals at 
ex:511nm by an Olympus IX70 inverted epi-
fluorescence microscope in combination with an 
Ultrapix camera and a computer with PTI imaging 
software, as previously described [26]. 
Caspase 3/7 Activity Assay 
 MIN6 cells were seeded onto a 96 well 
plate and treated. 48 hours treatment with 400μM 
palmitic acid was used to induce apoptosis as a 
positive control. Cleaved caspase 3/7 was assayed 
according to the manufacturer’s protocol (G8091, 
Promega, Wisconsin, USA).
xCelligence  
 The xCelligence system was operated 
according to the instructions in the user’s manual 
(ACEC Biosciences Inc., San Diego, USA). 
Briefly, MIN6 cells were seeded on to 96 well E-
plates and then cell growth was monitored and 
recorded as Cell Index (CI) values every 15 
minutes over 50 hours.  
MYTH Analysis of GLP1R in Human and 
Mouse Islet cDNA Library  
 The MYTH analysis was performed by 
Dualsystem Biotech Inc (Schlieren, Switzerland). 
The technology and the bait vector pCCW-ste-
hGLP1R-cub were described in previous studies 
[27,28].  
Statistics 
 Statistical significance was assessed using 
the Student’s t-test, Welsh t-test, one-way or two-
way ANOVA for repeated measures followed by a 
Bonferroni post-test comparison where required.  
P<0.05 was considered significant. All data is 
presented as mean ± SEM. 
RESULTS  
ZIP Family Gene Expression in MIN6 Cells 
and Human, and Mouse Islets 
 Several reports have examined the 
expression of ZIP isoforms in tissues including the 
GI-tract, central and peripheral nervous systems, 
prostate, liver, kidney, and pancreas 
[4,29,30,31,32,33]. Here, we profile the expression 
of all 14 ZIP isoforms (Slc39a1-14) in human and 
mouse pancreatic islets and MIN6 pancreatic beta 
cells. Among the genes examined, ZIP6 and ZIP7 
were the most abundantly expressed in both islets 
and MIN6 cells. We found the expression level of 
ZIPs was comparable between MIN6 cells and 
mouse islets with the exceptions of ZIP4, ZIP5, 
and ZIP8 (Fig.1A). In human islets, we found 
ZIP3, ZIP8, ZIP9 and ZIP14 expressed at 
comparable levels to ZIP6 and ZIP7 (Fig.1B). 
Since zinc plays important roles in pancreatic beta 
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cell function, and ZnT8 has been identified as a 
key risk loci for type 2 diabetes (T2D) in genome-
wide association studies (GWAS), it is reasonable 
for us to speculate that there may also be a 
dysregulated ZIP expression profile in islets from 
diabetic patients. Indeed, we observed a general 
trend (without statistical significance) of an altered 
ZIP expression profile in T2D islets compared 
with those obtained from normal glucose tolerant 
individuals (Fig.1B).    
Cellular Localization of ZIP6 and ZIP7 
 As noted above, ZIP6 and ZIP7 are the 
most abundantly expressed ZIP genes in MIN6 
cells, human, and mouse islets. In order to study 
the function of ZIP6 and ZIP7 in pancreatic beta 
cells, we first examined their endogenous 
expression. By using antibodies specifically 
detecting ZIP6, ZIP7, and insulin, we 
demonstrated that in islet cells endogenous ZIP6 
and ZIP7 are mainly expressed in insulin-
producing beta cells (Figure 2A&B). Detailed 
cellular localization of endogenous ZIP6 and ZIP7 
was then further examined on dispersed islet cells 
as outlined below. Studies performed on other cell 
types have suggested ZIP6 is primarily localized 
to the ER under basal state and translocates to the 
plasma membrane under a stimulatory condition 
[19,34] while ZIP7 is primarily co-localized to 
golgi or ER structures [32,35,36,37]. Co-staining 
ZIP6 or ZIP7 with either a plasma membrane 
marker (membrane fusion SNARE protein: 
Syntaxin-1a) or an ER marker (ER predominantly 
expressed protein: KDEL) revealed that both ZIP6 
and ZIP7 co-localized predominantly with the ER 
(Fig.2C&D) in dispersed pancreatic islet cells. 
Quantitative Pearson’s Correlation Coefficient 
calculations supported this co-localization between 
ZIP6 and ZIP7 with the ER (Fig.2G). Interestingly, 
after glucose stimulation, the majority of ZIP6 
protein translocates from the ER to the plasma 
membrane (Fig.2E), consistent with what has been 
previously observed in breast cancer cells [19], 
while ZIP7 remains unchanged (Fig.2F). 
Quantitative Pearson’s Correlation Coefficient 
calculations also show a significant increase in the 
co-localization of ZIP6 and the plasma membrane 
upon glucose stimulation (Fig.2H).  
SiRNA-Targeted ZIP6 and ZIP7 Knock-down 
in MIN6 Pancreatic Beta Cells
 To examine the potential role of ZIP6 and 
ZIP7 in vitro, we used targeted siRNA for ZIP6 
and ZIP7 knock-down in MIN6 beta cells. A 
knock-down efficiency of 70-80% was achieved 
for both ZIP6 and ZIP7 (Fig.3A&B). Interestingly, 
when we knocked-down ZIP6, we observed a 
significant increase in ZIP7 expression (Fig.3A). 
On the other hand, ZIP7 down-regulation did not 
cause any change in other ZIPs’ expression 
(Fig.3B). These findings suggest a possible co-
operative role between ZIP6 and ZIP7, thus we 
used the transcriptional silencing of both ZIP6 and 
ZIP7 in subsequent functional studies. A 50-60% 
reduction in both ZIP6 and ZIP7 mRNA was 
achieved with no significant effect on the 
expression of other ZIP isoforms or ZnT8 (Fig.3C).  
Analysis of Cytosolic Zinc Content in MIN6 
Beta Cells and Primary Mouse Islet Cells  
 To evaluate the role of ZIP6 and ZIP7 in 
regulating cytosolic zinc influx in live beta cells, 
zinc uptake capacity and concentration was 
recorded from cells loaded with Fluozin 3AM as a 
cytosolic zinc indicator. Overexpression of both 
transporters simultaneously induced a significant 
increase in zinc uptake upon addition of 
exogenous ZnSO4 (Fig.4A&B&C). The significant 
increase in cytosolic zinc content was sustained in 
these cells over time (Fig.4B). In complimentary 
studies, down-regulation of both ZIP6 and ZIP7 
expression did not affect basal zinc uptake, but 
significantly reduced glucose-stimulated zinc 
uptake in dispersed primary mouse islet cells in 
the presence of ZnSO4 (Fig.4D-F). Previous 
studies have shown that glucose can activate zinc 
flux, and thus raise cytosolic zinc levels in 
pancreatic beta cells [14,17,38]. Here we have 
demonstrated an important role for ZIP6 and ZIP7 
in this process.  
Cytosolic Zinc Content is Essential for GSIS in 
MIN6 Beta Cells 
 As we and others have reported previously, 
zinc efflux transporter ZnT8 regulates insulin 
secretion in part through alterations in insulin 
secretory granule zinc content [6,7]. We 
hypothesized that zinc influx transporters may 
have a role in insulin secretion via alterations in 
cytosolic and/or organelle-specific zinc pools. 
Double knock-down of ZIP6 and ZIP7 in MIN6 
beta cells significantly impaired insulin secretion 
upon stimulation with high glucose and the 
secretagogue KCl (Fig.5A&B). Interestingly, the 
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reduction in insulin secretion was not observed in 
MIN6 cells in which ZIP6 or 7 was knocked down 
individually (data not shown), further suggesting 
that a compensatory effect may exist between 
these ZIP isoforms (Fig 3A&B). The impairment 
in glucose-stimulated insulin secretion was not due 
to measurable alterations in insulin biosynthesis, 
as total insulin content was not altered (Fig.5C), 
nor was expression of key genes involved in 
proinsulin biosynthesis (Fig.5G).  
 To better delineate if impairedinsulin 
secretion in ZIP6 and ZIP7 knock-down cells is 
caused by reduced cellular zinc content, we 
utilized a zinc chelator, TPEN, [39,40,41], to 
mimic this condition. TPEN reduced insulin 
secretion in a dose-dependent manner when 
stimulated with glucose (Fig.5D) or KCl (Fig.5E). 
In line with previous studies [42,43], TPEN dose-
dependently affected insulin content, with low 
concentrations (2.5 and 5μM) having no effect, but 
a higher concentration (10μM) decreasing insulin 
content in MIN6 cells (Fig.5F). Taken together, 
the data strongly suggests that ZIP6 and ZIP7 are 
important for maintaining cytosolic zinc content 
and thus regulating insulin secretion and 
biosynthesis in pancreatic beta cells.  
Down-regulation of ZIP6 and ZIP7 Expression 
Induces Oxidative Stress But Not Apoptosis  
 The decreased insulin secretion in ZIP6 
and ZIP7 knock-down cells could be caused by 
impairment of the stimulus-secretion coupling 
apparatus, exocytotic machinery, and/or through 
induction of cell toxicity and death. Increasing 
evidence suggests that zinc content changes can 
trigger oxidative stress, causing apoptosis 
[44,45,46]. To examine this, CellROX® Deep Red 
was used to measure a broad range of reactive 
oxygen species (ROS) in MIN6 beta cells. 
Interestingly, a significant increase in ROS was 
observed in ZIP6 and ZIP7 knock-down cells 
(Fig.6A&B). This was similar to a response 
induced by treatment with palmitic acid, a known 
inducer of oxidative stress. However, we observed 
no changes in cleaved caspase 3/7 activity [47,48] 
after down-regulation of ZIP6 and ZIP7 
expression (Fig.6C), ruling out apoptosis. 
Concurrently we also employed the xCELLigence 
system to record cell proliferation in real-time. We 
observed no significant difference over 50 hours 
during siRNA treatment (Fig.6D). Thus, impaired 
GSIS with ZIP6 and ZIP7 knock-down is 
associated with increased ROS, but not due to cell 
death. 
Down-regulation of ZIP6 and ZIP7 Expression 
Does Not Affect Glucose Metabolism or 
Calcium Flux 
 Recent studies have indicated a potential 
role for ZIP7 in the regulation of glucose 
metabolism in skeletal muscle cells [49]. In order 
to determine whether ZIP6 and ZIP7 knock-down 
impairs glucose metabolism and thus reduces 
GSIS, we used real-time live imaging (PTI) to 
record mitochondrial membrane potential (MMP) 
changes upon acute glucose load. In dispersed 
mouse islet cells, no difference was observed in 
glucose-stimulated hyperpolarization of the MMP 
between scramble and ZIP6 and ZIP7 siRNA 
treated cells (Fig.7A). In agreement with this 
result, the expression of key genes involved in 
glucose uptake (GLUT 2: glucose transporter 2) 
and metabolism (GCK: glucokinase) were not 
attenuated with ZIP6 and ZIP7 knock-down 
(Fig.7B). Many studies have suggested a 
synergistic role between Zn2+ and Ca2+ in the 
regulation of intracellular kinase-activated 
signalling pathways [50,51,52,53]. Our lab has 
previously shown that voltage-gated calcium 
channels (VGCC) act as relatively specific zinc 
influx transporters [14], suggesting a possible role 
for zinc in the regulation of cytosolic calcium 
homeostasis. Glucose-stimulated cytosolic calcium 
influx is a vital part of the stimulus-secretion 
coupling pathway and for insulin granule 
exocytosis in pancreatic beta cells [24,54,55]. 
Here we examined whether the disruption in 
cytosolic zinc homeostasis observed in ZIP6 and 
ZIP7 knock-down MIN6 cells alters cytosolic 
calcium signalling to impair insulin secretion. 
Interestingly, no change was observed in glucose-
stimulated cytosolic calcium influx upon ZIP6 and 
ZIP7 knock-down (Fig.7C). Taken together, these 
results indicate that impairment of GSIS upon 
ZIP6 and ZIP7 knock-down is neither due to 
impaired glucose metabolism nor alterations in 
cytosolic calcium influx.  
Down-regulation of ZIP6 and ZIP7 Expression 
Impairs Insulin Exocytosis
 The absence of alterations to glucose 
metabolism and stimulus-secretion coupling in 
ZIP6 and ZIP7 knock-down cells led us to 
examine insulin exocytosis. We initially employed 
Transmission Electron Microcopy (TEM) to look 
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for differences in granule morphology and 
distribution. Previously, we and others have 
demonstrated that altered zinc homeostasis 
through ZnT8 deletion leads to atypical insulin 
crystallization within granules, which may alter 
granule docking and exocytosis [6,7]. TEM 
images revealed no differences in the number of 
dense-core looking insulin granules in MIN6 cells 
upon ZIP6 and ZIP7 knock-down (data not shown). 
Next, we examined insulin granule secretory 
dynamics by the time-lapse total internal reflection 
fluorescence (TIRF) microscopy. Here, insulin 
granules in dispersed mouse islet beta cells were 
tagged with neuropeptide Y (NPY)-EGFP by 
adenovirus transduction followed by siRNA-
mediated ZIP6 and ZIP7 knock-down. As 
previously shown, ~50-60% knock-down of ZIP6 
and ZIP7 was observed (Fig.8A). A significant 
reduction in the insulin granule exocytosis rate 
(fusion events) during the 1st phase of insulin 
secretion was observed by TIRF in ZIP6 and ZIP7 
knock-down islet cells (Fig.8B, C, D, E&F). Thus, 
in ZIP6 and ZIP7 knock-down beta cells, the 
reduced glucose-stimulated insulin granule 
docking can explain impaired glucose-stimulated 
insulin secretion. 
Effect of ZIP6 and ZIP7 on GLP-1 Mediated 
Signalling
 GLP-1, acting via GLP-1 receptor (GLP-
1R), has a well-established stimulatory effect on 
glucose-induced insulin secretion from pancreatic 
islets [56] and it protects rodent beta cells from 
cytokine induced apoptosis [57]. Interestingly, in 
concurrent studies, ZIP6 and ZIP7 were both 
identified as putative GLP-1R interacting proteins 
in a membrane yeast two hybrid (MYTH) screen 
of human and mouse islet cDNA libraries. This 
method was very similar to what we had 
previously reported for GLP-1R using a fetal brain 
cDNA library [28]. The interaction between 
ZIP6/ZIP7 and GLP-1R was validated using co-
immunoprecipitation (Fig.9A). Since the 
interaction between ZIP6 and ZIP7 and GLP-1R 
indicates a potential functional role for ZIPs in the 
regulation of GLP-1 signaling, we disrupted the 
interaction between ZIPs and GLP-1R utilizing 
siRNA mediated down-regulation of both ZIP6 
and ZIP7 expression. Although a reduction in 
insulin secretion was observed upon GLP-1 
treatment, the relative stimulatory effect of GLP-1 
on glucose-stimulated insulin secretion remained 
unchanged compared to scramble control (Fig.9B). 
Thus, ZIP6 and ZIP7 are not required for GLP-1 
augmented glucose-stimulated insulin secretion. 
To determine if ZIP6 and ZIP7 are involved in 
mediating GLP-1’s anti-apoptotic effect, we 
utilized exendin 4 (EX4, a GLP-1R agonist) and 
palmitic acid as proapoptotic stimulus. 
Interestingly, the down-regulation of ZIP6 but not 
ZIP7 completely diminished GLP-1’s protective 
effect against palmitic acid-induced apoptosis in 
MIN6 cells (Fig.9C). Correspondingly, down-
regulation of ZIP6 expression led to significantly 
reduced GLP-1-induced p-ERK (Fig.9D&E), one 
of the key signalling molecules thought to be 
involved in GLP-1’s anti-apoptotic effect [58,59]. 
Together, these findings suggests that ZIP6 is 
involved in GLP-1R signalling to prevent 
apoptosis but does not directly mediate its effect 
on insulin secretion. 
DISCUSSION 
 Since zinc ions are co-secreted together 
with insulin during insulin exocytosis, beta cells 
require mechanisms to continuously replenish zinc 
storage by uptake and incorporation into proper 
intracellular compartments. Despite the well-
established recognition of the tight relationship 
between zinc homeostasis and pancreatic beta cell 
function, the participating role of zinc influx 
transporters has so far not been well examined. 
Our observation of a possible dysregulated ZIP 
expression profile in type 2 diabetic islets 
compared to healthy individuals provides further 
rationale to investigate the role of ZIPs in the 
regulation of pancreatic beta cell function. We 
have previously demonstrated that VGCCs can 
mediate zinc uptake in pancreatic beta cells [14]. 
In the present study, we explore the role of two 
zinc influx transporter members of the ZIP family, 
ZIP6 and ZIP7, which we demonstrate here are 
two of the most highly expressed ZIP transcripts in 
human and mouse islets. Of note, in the present 
study, we observed a difference in the relative 
abundance of ZIP1 gene expression when 
compared to our previous work [14]; which 
showed relatively high expression. This may be 
due to different tissue samples, RNA extraction 
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methods or qPCR primer sets employed. However, 
the relative abundance of ZIP1 compared to other 
ZIP isoforms shown in current study is strikingly 
similar to the ZIP expression profiles of our more 
recent paper [7] as well as that published by 
Bellomo et al [17]. 
The cellular localization of ZIP6 and ZIP7 
suggest that these transporters can work in tandem 
to regulate cytosolic zinc content either by 
bringing extracellular zinc into cells [60,61,62] or 
by pumping ER-stored zinc into the cytosol when 
needed [35]. Importantly, in order to restore the 
cellular zinc content after glucose stimulation, 
ZIP6 appears to be capable of relocating to plasma 
membrane from the ER to facilitate zinc influx 
(Fig.2E&H). This is consistent with previous 
observations of ZIP6 activation in breast cancer 
cells [19]. Thus, ZIP6 and ZIP7 likely function to 
increase cytosolic zinc via increased uptake or 
reuptake of zinc under basal conditions and in 
response to glucose to replenish cellular and intra-
granular zinc during/after insulin secretion.  
Interestingly, a significant compensatory 
increase of ZIP7 expression occurred upon 
targeted siRNA knock-down of ZIP6, suggesting a 
tight cooperative relationship between ZIP6 and 
ZIP7. This led us to use a double knock-down or 
over-expression approach throughout our study. 
We performed population studies by using 
Cellomics®-based high-throughput screening 
platform where multiple cellular targets and 
processes occurring in live cells were analyzed 
over time and space in a non-biased way 
[44,63,64,65]. In agreement with previous findings 
in both dendritic cells [60] and breast cancer cells 
[37], impaired zinc homeostasis was observed 
after altered expression of ZIP6 and ZIP7. Notably, 
due to their subcellular localizations, the increase 
in cytosolic free zinc content we observed here in 
ZIP6 and ZIP7 overexpressed cells may result not 
only from enhanced influx of zinc ions from the 
extracellular space, but also from intracellular 
release from ER. The compensatory increase in 
ZIP7 we observed following ZIP6 knock-down 
suggests that zinc release from internal stores may 
also be critical to facilitate the process of insulin 
co-crystallization with zinc and its subsequent 
exocytosis, emphasizing the requirement for zinc 
in maintaining proper glucose-stimulated insulin 
secretion. Indeed, down-regulation of ZIP6 and 
ZIP7 expression together elicited a significant 
reduction in glucose-stimulated increase of 
cytosolic zinc content in dispersed mouse islet 
beta cells. However, previous studies from our lab 
[14], as well as a recent paper [17] both suggest 
that zinc can also enter cells via VGCC under 
glucose-stimulated conditions. In order to dissect 
the roles of VGCC and ZIPs in the regulation of 
cytosolic zinc content, we used the VGCC blocker, 
nifedipine (80uM), to acutely block the function of 
VGCCs, as we had previously reported [14]. In the 
presence of nifedipine, the knockdown of ZIP6 
and ZIP7 in MIN6 beta cells was still able to 
reduce glucose-stimulated cytosolic zinc 
accumulation (data not shown), suggesting that 
VGCC and ZIPs function independently to 
regulate cytosolic zinc content upon glucose 
stimulation. Although our data would indicate that 
ZIPs play a major role in regulating beta cell zinc 
content, further experiments are warranted to 
clearly assess the relative contribution of the 
VGCC in this process.   
Furthermore, knock-down of ZIP6 and 
ZIP7 disrupted zinc homeostasis and impacted 
overall beta cell function, as demonstrated by 
significantly impaired glucose- and depolarization 
(KCl)-stimulated insulin secretion. Again, 
consistent with a requirement of zinc for normal 
beta cell function, the zinc chelator TPEN caused 
depletion of cytosolic zinc content, which also 
lead to an impairment of beta cell function. 
However, under the experimental conditions used 
here, we observed no significant difference in 
either intracellular insulin content, nor expression 
levels of any genes involved in insulin 
synthesis/processing upon ZIP6 and ZIP7 knock-
down. This suggested insulin synthesis and 
processing were not altered. It is possible that 
decreased beta cell zinc accumulation caused by 
ZIP6 and ZIP7 knock-down may adversely affect 
zinc accumulation in the insulin granule, and thus 
adversely affect secretion. Indeed, we and others 
have previously demonstrated that reduced 
granular zinc in mice lacking the insulin granule-
specific zinc transporter, ZnT8, is associated with 
insulin crystallization defects and reduced 
secretion [7,12,13]. Although the down-regulation 
of ZIP6 and ZIP7 did not alter the expression of 
ZnT8, the impact of reduced cellular zinc content 
on intra-granular zinc concentration is unclear, and 
further studies are warranted to confirm the effect 
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of ZIP6 and ZIP7 knock-down on intracellular 
compartments of zinc.   
 Impairment of the ability to respond to the 
increased demand for insulin secretion is a key 
element of beta cell failure in T2D [66]. Here, we 
show a general trend towards the dysregulated 
expression of ZIPs in islets from T2D patients 
compared to normal glucose tolerant individuals. 
It is thus reasonable to speculate that reduced 
expression of key ZIPs, including ZIP6 and ZIP7, 
may disrupt zinc homeostasis and produce 
subsequent defects in insulin secretion and reduce 
beta cell viability, potentially increasing the risk of 
developing diabetes. There are numerous reports 
supporting a significant interaction between 
impaired zinc homeostasis and diabetes 
[67,68,69,70], and zinc supplementation has 
beneficial effects on improving glycemic control 
in diabetic patients [67,71,72]. Interestingly, our 
data suggest that increasing cellular zinc alone is 
not sufficient to enhance beta cell insulin secretion, 
as overexpression of ZIP6 and ZIP7 increased 
cytosolic zinc has no effect on insulin secretion in 
healthy beta cells. Therefore, zinc does not 
directly stimulate insulin secretion and must 
influence beta cell function perhaps protecting 
against specific forms of beta cell dysfunction to 
maintain insulin secretion.  
Our data strongly supports the idea that 
zinc, and by extension ZIP6 and ZIP7, has a 
protective role against beta cell dysfunction 
through numerous pathways. One possible role for 
zinc that is supported by our findings is in the 
process of granule docking and insulin exocytosis. 
The actin cytoskeleton is considered the key 
mediator of biphasic insulin release, as it regulates 
insulin granule docking at the cell periphery [73], 
and zinc has previously been shown to regulate 
cytoskeleton dynamics as an important component 
in stabilizing microtubule structure in neurons [74]. 
In our study, we observed that down-regulation of 
ZIP6 and ZIP7 resulted in fewer docked granules 
during both 1st and 2nd phase insulin secretion, 
indicating a defect in actin cytoskeleton-mediated 
exocytosis. Interestingly, defects in 1st phase 
insulin secretion are characteristic of T2D, 
consistent with a possible reduction in ZIP7 
expression in diabetics. Therefore, we suggest here 
that there may exist a functional relationship 
between cytosolic zinc homeostasis and insulin 
exocytosis mediated by a zinc-facilitated 
remodelling of the actin cytoskeleton.  
Oxidative stress is strongly associated 
with beta cell dysfunction in the development of 
T2D, and previous studies have shown that 
maintaining the optimal cellular zinc content is 
critical for preventing oxidative stress and 
subsequent cell death in various cell types 
[75,76,77,78]. Superoxide Dismutases (SODs) act 
as one of the major anti-oxidant enzymes to 
protect pancreatic beta cells from being damaged 
by ROS. Zinc is the cofactor of SOD, and is 
essential for maintaining proper SOD activity [79]. 
Studies have shown that both SOD expression and 
activity are diminished in zinc deficient cells 
[80,81]. Indeed, here we show a significant 
increase in ROS production upon disrupted 
cytosolic zinc homeostasis due to the down-
regulation of ZIP6 and ZIP7 expression, which 
may also play a partial role in the observed 
pancreatic beta cell dysfunction. Therefore, 
maintenance of zinc homeostasis through ZIP6 
and ZIP7 may play an essential protective role 
against the development of oxidative stress.  
Finally, we made the interesting 
observation that ZIP6 is an important cellular 
interactor with the GLP-1 receptor and is required 
for the protective effect of GLP-1 against palmitic 
acid-induced beta cell apoptosis. Lipotoxicity is 
thought to be a major underlying cause of beta cell 
death and dysfunction in T2D, thus loss of ZIP6 
would make beta cells more susceptible to death. 
Therefore, ZIP6 and ZIP7 may be essential for 
maintaining beta cell function and survival during 
periods of stress, such as oxidative stress and 
lipotoxicity. These ZIPs are also likely critical for 
proper insulin granule exocytosis and appropriate 
1st phase insulin secretion. 
 In summary, the present study shows that 
ZIP6 and ZIP7 are novel and important zinc influx 
transporters in pancreatic beta cells. We 
demonstrated that maintenance of cytosolic zinc 
homeostasis through these transporters is 
functionally important for pancreatic beta cells to 
maintain normal insulin exocytosis and thus 
insulin secretion. Interestingly, we also show ZIP6 
functions as a cellular interactor with GLP-1 
receptor and participates in mediating the effect of 
GLP-1 to alleviate beta cell apoptosis. Finally, our 
study suggests that these ZIP transporters (ZIP6 
and ZIP7) may represent novel targets for drugs 
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that can enhance beta cell survival and insulin 
secretion. 
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FIGURE LEGEND 
Figure 1. ZIP Family Gene Expression in MIN6 Cells and Human and Mouse Islets 
Quantitative PCR analysis of ZIP transcriptome in A) MIN6 beta cells and mouse islets, n=4-6 and (B) 
Human islets from normal glucose tolerant and type 2 diabetic individuals, n=5-13. Values were 
normalized to beta-actin mRNA and represented as mean ± SEM. 
Figure 2. Cellular Localization of ZIP6 and ZIP7 
A&B) Representative confocal images of endogenously expressed ZIP6 and ZIP7 in dispersed mouse 
islet cells (Blue: Nucleus; Red: ZIP6 or ZIP7; Green: Insulin; arrows indicate pancreatic beta cells). 
Representative confocal images of endogenously expressed ZIP6 and ZIP7 co-stained with C&D) ER 
marker (KDEL) or E&F) membrane marker (syntaxin-1a) in the basal or glucose-stimulated state 
(20mM glucose, 5mins) (Blue: Nucleus; Red: Membrane or ER; Green: anti-ZIP6 or anti-ZIP7). 
Quantitative analysis by Pearson Correlation Coefficient shows co-localization between ZIP6 and ZIP7 
with G) ER or H) plasma membrane. n=3-4. Values were represented as mean ± SEM. *P<0.05. 
Figure 3. SiRNA Targeted ZIP6 and ZIP7 Knock-down in MIN6 Pancreatic Beta Cells
QPCR analysis of ZIP transcriptome expression upon A) ZIP6 single knock-down, B) ZIP7 single knock-
down, and C) ZIP6 and ZIP7 double knock-down. A non-specific targeted scramble SiRNA sequence was 
used as the control. n=4-5. Values were normalized to beta-actin and represented as mean ± SEM. 
*P<0.05. 
Figure 4. Analysis of Cytosolic Zinc Content in MIN6 Beta Cells and Primary Mouse Islet Cells  
Time course of cytosolic zinc content on cultured live beta cells analyzed by the high throughput high 
content analysis machine, ThermoScientific Cellomics®. A) Representative images taken during the time 
course of cytosolic zinc content analysis upon ZIP6 and ZIP7 double over-expression. B) Quantitative 
analysis and C) corresponding area under the curve of the time course of cytosolic zinc content analysis 
upon ZIP6 and ZIP7 double over-expression. D) Representative images taken during the time course of 
cytosolic zinc content analysis upon ZIP6 and ZIP7 double knock-down. E) Quantitative analysis and F) 
corresponding area under the curve of the time course of cytosolic zinc content analysis upon ZIP6 and 
ZIP7 double knock-down. n=3-4, with 10,000-15,000 individual cells in each experiment; Values were 
represented as mean ± SEM.*P<0.05, **P<0.01, ***P<0.001. 
Figure 5. Cytosolic Zinc Content is Essential for GSIS in MIN6 Beta Cells 
Glucose- and KCl-stimulated insulin secretion was performed upon A&B) ZIP6 and ZIP7 double knock-
down, and D&E) 1 hour TPEN pre-treatment. Intracellular insulin content measured upon C) ZIP6 and 
ZIP7 double knock-down and F) 1 hour TPEN pre-treatment. Insulin levels were normalized to DNA 
content for each treatment. G) Quantitative PCR analysis comparing gene expression levels of INS1, PC1, 
PC2, PDX1, MAFA and CPE between scramble and ZIP6 and ZIP7 siRNA treated MIN6 cells. A non-
specific scramble siRNA sequence was used as control. n=5-6; Values were represented as mean ± 
SEM.*P<0.05, **P<0.01, ***P<0.001. 
Figure 6. Down-regulation of ZIP6 and ZIP7 Expression Induces Oxidative Stress But Not 
Apoptosis  
A) Representative images taken by ThermoScientific Cellomics® high throughput machine during ROS 
measurement upon ZIP6 and ZIP7 knock-down, and B) quantitative analysis of ROS measurements. C) 
Cell death study (cleaved caspase-3/7 activity) upon ZIP6 and ZIP7 knock-down. 400uM palmitic acid 
was used as an inducer of oxidative stress and apoptosis. D) MIN6 cell growth was continuously 
monitored by the xCelligence system along the process of cell seeding and siRNA treatment; n=4-5. 
Values were represented as mean ± SEM.*P<0.05, ***P<0.001. 
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Figure 7. Down-regulation of ZIP6 and ZIP7 Expression Does Not Affect Glucose Metabolism or 
Calcium Signalling 
A) Glucose-induced hyperpolarization of the mitochondrial membrane potential (MMP) was compared 
between scramble and ZIP6 and ZIP7 siRNA-treated mouse dispersed islet cells. B) Representative 
images from MMP assay. C) Quantitative PCR analysis and comparing the gene expression levels of 
GLUT2 and GCK between scramble and ZIP6 and ZIP7 siRNA-treated MIN6 cells. D) Glucose-induced 
cytosolic calcium content change examined and analyzed between scramble and ZIP6 and ZIP7 siRNA 
treated MIN6 cells. n=4-5. Values were represented as mean ± SEM.**P<0.01. 
Figure 8. Down-regulation of ZIP6 and ZIP7 Expression Impairs Insulin Exocytosis
A) Quantitative PCR analysis of ZIP6 and ZIP7 expression upon double knock-down in dispersed mouse 
islet cells. A non-specific scramble siRNA sequence was used as control. TIRF measuring was used to 
measure insulin exocytosis in dispersed mouse islet beta cells upon ZIP6 and ZIP7 double knock-down 
and adenovirus induced NPY-EGFP transfection. B) Representative TIRF image of docked insulin 
granules (red circles) in dispersed mouse islet beta cells. Histogram of fusion events occurring during first 
and second phase of glucose- and KCl-stimulated insulin secretion in C) scramble siRNA treated and D) 
ZIP6 and ZIP7 targeted siRNA treated mouse islet beta cells. E) Cumulative insulin granule fusion events 
normalized per cell per 100um2 during stimulation as indicated. F) Quantitative summary of total insulin 
granule fusion events in dispersed mouse islet beta cells. n=6. Values were represented as mean ± 
SEM.*P<0.05, **P<0.01. 
Figure 9. Effect of ZIP6 and ZIP7 on GLP-1 Mediated Signalling
A) Representative western blot of co-immunoprecipitation between GLP-1 receptor with ZIP6 and ZIP7 
respectively upon ZIP6 and ZIP7 overexpression. B) GSIS in INS1 cells and C) cleaved caspase 3/7 
activity was performed/measured with or without Exendin 4 treatment (100nM) upon ZIP6 and ZIP7 
knock-down.  D) Representative western blot and E) quantitative analysis of Exendin 4 (100nM)-induced 
phosphorylation of ERK1/2 (p44/42). n=3-5. Values were represented as mean ± SEM.*P<0.05.  
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